骨关节炎的发病因子揭晓:DMT1通过mir-17-5p/NEDD4调节轴驱动自依赖性铁亡
Guanglei Zhao1, Yue Shen2,3,4,5, Jingchun Ma1
1Department of Orthopedic Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Journal of orthopaedic translation
|March 16, 2026
概括
这项研究确定了在骨关节炎 (OA) 病变发生过程中新的DMT1-自 - 铁亡轴. 针对这一轴,包括铁灭抑制剂和NEDD4等上游调节剂,为OA提供了有希望的疾病修饰策略.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 骨关节炎 (OA) 是一种使人虚弱的关节疾病,目前没有疾病修饰疗法.
- 铁,一种依赖于铁的细胞死亡途径,有助于OA的进展.
- 在OA中,结合铁和自的确切机制尚不清楚.
研究的目的:
- 阐明二价金属载体1 (DMT1) 在OA期间自性铁亡中的作用.
- 根据DMT1-自 - 铁灭轴,确定OA的新型治疗点.
主要方法:
- 使用LASSO回归和随机森林模型选与OA相关的铁灭基因.
- 在IL-1β/埃拉斯刺激的胆固醇细胞和DMM诱导的OA小鼠模型中研究DMT1功能.
- 评估ferroptosis和自标志物,关节损伤以及涉及miR-17-5p和NEDD4.5的调节机制.
主要成果:
- 在OA软骨和软骨细胞中,DMT1被上调,与铁亡相关.
- 抑制DMT1减轻了OA的进展,而过度表达则使其恶化.
- DMT1激活了自,将其与铁亡的执行联系起来,自调节影响了铁亡水平.
结论:
- 一个新的DMT1-自 - 铁灭轴被确定为OA的关键机制.
- 铁灭抑制剂和上游调节剂,如miR-17-5p和NEDD4,显示了OA治疗的潜力.
- NEDD4代表了基于精确基因的OA治疗的有希望的目标.
相关概念视频
The JAK-STAT Signaling Pathway
13.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.7K
Regulated Protein Degradation
3.3K
3.3K
Regulated Protein Degradation
9.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.2K
TGF - β Signaling Pathway
10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
T Cell Types and Functions
3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K

